Medifast, Inc.
MED
$12.57
$0.171.37%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 76.04M | 75.10M | 89.41M | 105.56M | 115.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 76.04M | 75.10M | 89.41M | 105.56M | 115.73M |
| Cost of Revenue | 24.29M | 22.96M | 27.25M | 28.91M | 31.48M |
| Gross Profit | 51.76M | 52.14M | 62.16M | 76.64M | 84.25M |
| SG&A Expenses | 56.14M | 58.94M | 65.14M | 76.61M | 84.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 81.52M | 82.90M | 93.49M | 106.62M | 116.99M |
| Operating Income | -5.48M | -7.80M | -4.08M | -1.07M | -1.26M |
| Income Before Tax | -1.94M | -6.38M | -2.66M | 2.88M | 526.00K |
| Income Tax Expenses | 181.00K | 11.74M | -396.00K | 395.00K | 1.30M |
| Earnings from Continuing Operations | -2.12M | -18.12M | -2.26M | 2.48M | -772.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.12M | -18.12M | -2.26M | 2.48M | -772.00K |
| EBIT | -5.48M | -7.80M | -4.08M | -1.07M | -1.26M |
| EBITDA | -2.00M | -4.34M | -629.00K | 2.98M | 2.02M |
| EPS Basic | -0.19 | -1.65 | -0.21 | 0.23 | -0.07 |
| Normalized Basic EPS | -0.23 | -0.36 | -0.15 | 0.16 | -0.01 |
| EPS Diluted | -0.19 | -1.65 | -0.21 | 0.22 | -0.07 |
| Normalized Diluted EPS | -0.23 | -0.36 | -0.15 | 0.16 | -0.01 |
| Average Basic Shares Outstanding | 11.01M | 10.99M | 10.99M | 10.99M | 10.95M |
| Average Diluted Shares Outstanding | 11.01M | 10.99M | 10.99M | 11.06M | 10.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -4.10% | 0.00% | 0.00% | 0.04% | -25.13% |